Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive Disease.
Vujasinovic M. et al, (2025), United European gastroenterology journal, 13, 1583 - 1592
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH. et al, (2025), The New England journal of medicine, 392, 1168 - 1177
Exploring cardiovascular involvement in IgG4-related disease: a case series approach with cardiovascular magnetic resonance
Henry JA. et al, (2025), Heart, 111, 133 - 140
Enhancing Liver Fibrosis Measurement: Deep Learning and Uncertainty Analysis Across Multi-Centre Cohorts
Wojciechowska MK. et al, (2025)
Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD.
Motta RV. et al, (2024), Endoscopy international open, 12, E1285 - E1294
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Jones DEJ. et al, (2024), Hepatology (Baltimore, Md.), 80, 1291 - 1300
Prospective cohort for early detection of liver cancer (Pearl): a study protocol
Khanna K. et al, (2024), BMJ Open, 14, e085541 - e085541
Fibrotic phenotype of IgG4-related disease.
Lanzillotta M. et al, (2024), The Lancet. Rheumatology, 6, e469 - e480
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
Overbeek KA. et al, (2024), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22, 994 - 1004.e10
Challenges and pitfalls in the diagnosis of IgG4-related disease.
Bateman AC. and Culver EL., (2024), Seminars in diagnostic pathology, 41, 45 - 53
1H NMR Spectroscopy can distinguish steatotic liver disease and HCC in steatotic liver disease in a prospective patient cohort
Peters R. et al, (2024), GUT, 73, A37 - A37
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis.
Shah A. et al, (2024), Hepatology communications, 8
Human Leukocyte Antigen drives methylation signatures in primary sclerosing cholangitis but not in IgG4-related sclerosing cholangitis
Cabras S. et al, (2024), JOURNAL OF CROHNS & COLITIS, 18, i178 - i179
IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease.
Motta RV. and Culver EL., (2024), Frontiers in immunology, 15
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
Perugino C. et al, (2023), Rheumatology and therapy, 10, 1795 - 1808
Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study.
Schregel I. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 21, 3448 - 3450.e3
Investigating the cardiac manifestations of IgG4-related disease using cardiac magnetic resonance imaging
Henry JA. et al, (2023), European Heart Journal, 44
Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study.
Eder P. et al, (2023), Journal of Crohn's & colitis, 17, 1791 - 1799
Correspondence on ‘The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'
Peters RJR. et al, (2023), Annals of the Rheumatic Diseases, 82, e210 - e210